메뉴 건너뛰기




Volumn 26, Issue 15, 2016, Pages 3572-3576

An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria

Author keywords

Antimicrobials; E. faecalis; Mycobacterium tuberculosis; Oxazolidinone; Staphylococcus aureus

Indexed keywords

BIAPENEM; DORIPENEM; FROPENEM; OXAZOLIDINONE DERIVATIVE; TEBIPENEM; ANTIINFECTIVE AGENT;

EID: 84977596084     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2016.06.019     Document Type: Article
Times cited : (11)

References (36)
  • 12
    • 84963730907 scopus 로고    scopus 로고
    • Global Tuberculosis Report
    • WHO, World Health Organization Geneva
    • 12 WHO, Global Tuberculosis Report. 2015, World Health Organization, Geneva.
    • (2015)
  • 18
    • 80052865708 scopus 로고    scopus 로고
    • Susceptibility Testing of Mycobacteria, Nocardiae and Other Aerobic Actinomycetes
    • Clinical Laboratory Standard Institute M24-A2
    • 18 Desmond, E., Susceptibility Testing of Mycobacteria, Nocardiae and Other Aerobic Actinomycetes. 2011, Clinical Laboratory Standard Institute M24-A2.
    • (2011)
    • Desmond, E.1
  • 23
    • 0042908666 scopus 로고    scopus 로고
    • Antibiotics: Actions, Origins, Resistance
    • ASM Press Washington DC
    • 23 Walsh, C., Antibiotics: Actions, Origins, Resistance. 2003, ASM Press, Washington DC.
    • (2003)
    • Walsh, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.